Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Conard

Showing results (301-310 of 355) with videos related to

Pageof 36
Sort By:
Clinical Pharmacology and Therapeutics|May 1, 1988
The development and testing of intravenous dosing regimens: application to flecainide for the suppression of ventricular arrhythmiasT Wang, L A Siddoway, K A Thompson, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|December 1, 1989
[Intravenous thrombolysis with tissue plasminogen activator (rt-PA) at the prehospital phase of acute myocardial infarction. Apropos of 49 cases]P Cazaux, G Leclercq, A Vahanian, et al.
Fundamental & Clinical Pharmacology|January 1, 1988
Comparison of thrombolytic, fibrinolytic, and fibrinogenolytic properties of tissue plasminogen activator, streptokinase, single-chain urokinase, high molecular weight and low molecular weight urokinase in human plasma in vitroM Samama, G Nguyen, P Desnoyers, et al.
Annales De Medecine Interne|January 1, 1983
[4 cases of acquired Willebrand factor deficiency associated with monoclonal dysglobulinemia]M H Horellou, E Baumelou, N Sitbon, et al.
Contraception|September 27, 2015
Impact on hepatic estrogen-sensitive proteins by a 1-year contraceptive vaginal ring delivering Nestorone® and ethinyl estradiolD F Archer, M A Thomas, J Conard, et al.
The Biochemical Journal|November 1, 1989
A 32 kDa lipocortin from human mononuclear cells appears to be identical with the placental inhibitor of blood coagulationB Rothhut, C Coméra, S Cortial, et al.
Journal of Clinical Pharmacology|March 1, 1988
Oral flecainide pharmacokinetics in patients with impaired renal functionS C Forland, E Burgess, A D Blair, et al.
Journal of Human Evolution|June 20, 2015
On the evidence for human use and control of fire at SchöningenMareike C Stahlschmidt, Christopher E Miller, Bertrand Ligouis, et al.
British Journal of Haematology|August 1, 1993
Identification of nine novel mutations in type I antithrombin deficiency by heteroduplex screeningV Chowdhury, R J Olds, D A Lane, et al.
Clinical Pharmacology and Therapeutics|July 1, 1989
Identification of drug interactions by meta-analysis of premarketing trials: the effect of smoking on the pharmacokinetics and dosage requirements for flecainide acetateJ L Holtzman, C E Weeks, D C Kvam, et al.
Pageof 36

Showing results (301-310 of 355) with videos related to

Sort By:
Pageof 36
Clinical Pharmacology and Therapeutics|May 1, 1988
The development and testing of intravenous dosing regimens: application to flecainide for the suppression of ventricular arrhythmiasT Wang, L A Siddoway, K A Thompson, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|December 1, 1989
[Intravenous thrombolysis with tissue plasminogen activator (rt-PA) at the prehospital phase of acute myocardial infarction. Apropos of 49 cases]P Cazaux, G Leclercq, A Vahanian, et al.
Fundamental & Clinical Pharmacology|January 1, 1988
Comparison of thrombolytic, fibrinolytic, and fibrinogenolytic properties of tissue plasminogen activator, streptokinase, single-chain urokinase, high molecular weight and low molecular weight urokinase in human plasma in vitroM Samama, G Nguyen, P Desnoyers, et al.
Annales De Medecine Interne|January 1, 1983
[4 cases of acquired Willebrand factor deficiency associated with monoclonal dysglobulinemia]M H Horellou, E Baumelou, N Sitbon, et al.
Contraception|September 27, 2015
Impact on hepatic estrogen-sensitive proteins by a 1-year contraceptive vaginal ring delivering Nestorone® and ethinyl estradiolD F Archer, M A Thomas, J Conard, et al.
The Biochemical Journal|November 1, 1989
A 32 kDa lipocortin from human mononuclear cells appears to be identical with the placental inhibitor of blood coagulationB Rothhut, C Coméra, S Cortial, et al.
Journal of Clinical Pharmacology|March 1, 1988
Oral flecainide pharmacokinetics in patients with impaired renal functionS C Forland, E Burgess, A D Blair, et al.
Journal of Human Evolution|June 20, 2015
On the evidence for human use and control of fire at SchöningenMareike C Stahlschmidt, Christopher E Miller, Bertrand Ligouis, et al.
British Journal of Haematology|August 1, 1993
Identification of nine novel mutations in type I antithrombin deficiency by heteroduplex screeningV Chowdhury, R J Olds, D A Lane, et al.
Clinical Pharmacology and Therapeutics|July 1, 1989
Identification of drug interactions by meta-analysis of premarketing trials: the effect of smoking on the pharmacokinetics and dosage requirements for flecainide acetateJ L Holtzman, C E Weeks, D C Kvam, et al.
Pageof 36